Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
arcticnovartis
- Shareholders approve 27th consecutive dividend increase to CHF 3.30 (+3.1%) per share for 2023; representing a 3.7% yield1 and approximately 58% payout of free cash flow
- Shareholders confirm Joerg Reinhardt as Chair of the Board of Directors as well as all other current members